Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Caliper Life Sciences Awarded EPA Contract

Published: Tuesday, April 10, 2007
Last Updated: Tuesday, April 10, 2007
Bookmark and Share
Caliper Discovery Alliances and Services unit will test environmental chemicals under EPA’s ToxCast research program.

Caliper Life Sciences, Inc. has announced that the United States Environmental Protection Agency (EPA) has awarded a contract to NovaScreen Biosciences, the in vitro discovery services arm of Caliper Discovery Alliances and Services (CDAS), to assist the agency in developing new approaches to identify toxic environmental chemicals.

The contract award, which was anticipated by Caliper, will range from $1.4 to $69 million over the course of two to five years. The specific dollar value within this range will be based primarily upon the volume of testing requested by the EPA and the availability of funds for future years.

As part of the EPA’s ToxCast research program, CDAS will utilize biochemical and cellular assays, validated in the pharmaceutical drug discovery industry, to help predict how chemicals such as pesticides will interact with the environment, humans and animals.

CDAS will leverage its screening tools and its proprietary Side-Effect Database (SED), representing screening results from 2,300 compounds tested against more than 70 biological targets, to provide comprehensive laboratory testing and analysis services across a broad range of specific protein targets of interest to the EPA.

“A contract of this magnitude validates industry demand for CDAS; organizations require a reliable service-oriented provider of leading-edge technologies that delivers timely, high quality results,” said Kevin Hrusovsky, CEO of Caliper Life Sciences.

“Our work with the EPA is an extension of the services we successfully provide for our pharma and biotech customers,” Hrusovsky continued.

“The EPA needed a partner to perform fast, accurate screening of a high volume of compounds and the technical expertise to help build relevant predictive datasets,” said David Manyak, Ph.D., executive vice president of discovery services of Caliper Life Sciences.

“CDAS was selected by the EPA, in a highly competitive award process, based on our superior technical proposal, data quality plan and value offering. We are gratified by this validation of our capabilities and excited to work with the EPA on this important program that will result in a healthier, safer environment,” Manyak added.

Caliper Discovery Alliances & Services (CDAS) is the newly-formed services organization created from the integration of NovaScreen Biosciences, a provider of in vitro discovery services, and Xenogen Biosciences, a provider of in vivo discovery services.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Caliper LS Receives $1.1 Million Task Order from the EPA's ToxCast™ Screening Program
This task order was issued pursuant to a contract that Caliper was awarded by the EPA in April 2007 under the ToxCast program.
Wednesday, August 20, 2008
Caliper Life Sciences Forms Alliance with Horizon Discovery
CDAS expands offering to include screening for targeted cancer drugs using genetically-defined in-vitro human disease models.
Thursday, April 10, 2008
Caliper Life Sciences Launches Drug Discovery and Development Services Business
Caliper combines in vitro and in vivo services of Novascreen Biosciences and Xenogen Biosciences to form Discovery Alliances & Services.
Tuesday, January 09, 2007
Caliper Strengthens Distribution Channels in China, Hong Kong and India
Leading international distributors expand customer access to Caliper microfluidics and drug discovery technologies.
Monday, February 13, 2006
Caliper Completes Acquisition of NovaScreen
The acquisition combines NovaScreen's screening, profiling and assay development services with Caliper's LabChip® and liquid handling products.
Thursday, October 06, 2005
Caliper Technologies expands Caliper 250 system

Monday, March 10, 2003
Caliper cut's Amphora Discovery's purchase obligations

Tuesday, December 17, 2002
Zymark Supplies HTS Systems to Vertex Pharmaceuticals

Tuesday, October 15, 2002
Scientific News
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
The Light of Fireflies for Medical Diagnostics
EPFL scientists have exploited the light of fireflies in a new method that detects biological molecules without the need for complex devices and high costs.
Vital Protein in Healthy Fertilization Process Identified
Researchers at the National Institutes of Health have discovered a protein that plays a vital role in healthy egg-sperm union in mice.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!